Nearly 1 Million Bottles of Heart Disease and Kidney Drugs Recalled
News

Nearly 1 Million Bottles of Heart Disease and Kidney Drugs Recalled

July 3, 2026

If your medication is on the recall list, check the FDA's report for the lot code and expiration date to see if your specific bottle is affected.

By Jenna Anderson 

At A Glance
Amgen recalled nearly 1 million bottles of Corlanor and Sensipar, medications for heart failure and kidney disease, respectively.
The Corlanor may contain a foreign substance, and the Sensipar may have quality issues.
Check with your healthcare provider or pharmacist before stopping a medication suddenly.

Check your medicine cabinet: Two common prescription drugs, Corlanor and Sensipar, have been recalled. In early June, manufacturer Amgen recalled a total of nearly 1 million bottles of the medications.

Corlanor, a heart failure drug, was recalled due to a potential foreign substance, while Sensipar, for kidney disease, may have deviations from the Current Good Manufacturing Practice (CGMP), which ensures the identity, strength, quality, and purity of drugs.

On June 23, the Food and Drug Administration (FDA) gave the recall the second-highest risk level, Class II, meaning the affected medications may cause temporary or reversible effects, but the risk of serious consequences is low.

What to Look For

Corlanor (Ivabradine) Tablets, 5 mg

  • Size: 14-tablet bottles, with NDC: 55513-800-99
  • Size: 60-tablet bottles, with NDC: 55513-800-60

Corlanor (Ivabradine) Tablets, 7.5 mg

  • Size: 60-tablet bottles
  • NDC: 55513-810-60

Sensipar (Cinacalcet) Tablets, 30 mg

  • Size: 30-tablet bottles
  • NDC: 55513-073-30

Sensipar (Cinacalcet) Tablets, 60 mg

  • Size: 30-tablet bottles
  • NDC: 55513-074-30

Sensipar (Cinacalcet) Tablets, 90 mg

  • Size: 30-tablet bottles
  • NDC: 55513-075-30

What You Should Do

If your medication is on the recall list, check the FDA’s report for the lot code and expiration date to see if your specific bottle is affected.

If it is, contact your healthcare provider or pharmacist to determine the best course of action. Class II recalls carry safety risks, but suddenly stopping a medication can sometimes be riskier, Jennifer Young, PharmD, BCPS, CSP, lead medication safety specialist at the Institute for Safe Medication Practices, previously told Health.

“While recall notifications can be frightening,” she said, “it’s important to contact your healthcare provider right away for advice before making any changes to your medication routine.”

The post by SouthFloridaReporter.com appears on South Florida Reporter.

VIP Journal Media

Need Premium Media Services?

Web Design
Brand Identity
Print Production
Explore Our ServicesTrusted by South Florida's leading brands